title: Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
authors.affiliation: Department of Thoracic-Cardiovascular Surgery, Cardiovascular Institute, Loyola University Medical Center, Maywood, IL, USA.
authors.forename: Walter P
authors.initials: WP
authors.lastname: Jeske
authors.forename: Jeanine M
authors.initials: JM
authors.lastname: Walenga
mesh_terms: D000721:Ancrod / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D000991:Antithrombins / Q000627:therapeutic use; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000009:adverse effects* / Q000276:immunology; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000188:drug therapy* / Q000503:physiopathology; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D000991:Antithrombins; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin; D006493:Heparin; D000721:Ancrod